Cargando…
P059 The overexpression of efflux pump gene cdr1B resulting in voriconazole- and isavuconazole- resistance in Aspergillus fumigatus recovered from a patient with chronic pulmonary aspergillosis in China
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Triazole resistance in the pathogenic Aspergillus fumigatus has been increasing worldwide, posing a growing therapeutic challenge. To date, triazole resistance in clinical isolates of A. fumigatus causing pulmonary aspergillosis...
Autores principales: | Liang, Tianyu, Wang, Qiqi, Pan, Shiyang, Ni, Fang, Li, Ruoyu, Wan, Zhe, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509746/ http://dx.doi.org/10.1093/mmy/myac072.P059 |
Ejemplares similares
-
Therapeutic efficacy of isavuconazole in experimental Aspergillus fumigatus endophthalmitis
por: Guest, John, et al.
Publicado: (2017) -
Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis
por: Mehta, Hijab, et al.
Publicado: (2008) -
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
por: Harrington, Rachel, et al.
Publicado: (2016) -
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
por: Floros, Lefteris, et al.
Publicado: (2019) -
Aspergillus fumigatus Can Display Persistence to the Fungicidal Drug Voriconazole
por: Scott, Jennifer, et al.
Publicado: (2023)